Summary & Overview
CPT 3046F: HbA1C Result Greater Than 9%
CPT code 3046F denotes an HbA1C result greater than 9%, flagging poorly controlled diabetes. Nationally, this code is clinically significant because it identifies patients at higher risk for diabetes complications and signals opportunities for treatment adjustment, care coordination, and quality measurement. Payers use this performance measure in population health management, quality reporting, and risk stratification.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the code, the typical service setting, and an overview of how payers treat high A1C levels in quality frameworks. The publication summarizes benchmarks and performance implications where available and highlights policy-relevant considerations for coverage and reporting. It is intended to inform clinicians, billing professionals, and policymakers on the code’s meaning, typical use cases, and utility in national chronic disease management programs.
Data not available in the input for specific payer rates, modifiers usage patterns, associated taxonomies, ICD-10 mappings, and related codes.
Billing Code Overview
CPT code 3046F indicates a recent HbA1C (A1C) level greater than 9%. The A1C test is a blood test that reflects average blood glucose over the prior 2–3 months and is used to assess whether a patient with diabetes has adequate glycemic control. A result above 9% signals poorly controlled diabetes and may prompt clinical reassessment of the patient’s diabetes management.
-
Service type: Laboratory test result reporting and chronic disease monitoring
-
Typical site of service: Outpatient clinics, primary care offices, endocrinology practices, and clinical laboratories
Data not available in the input for payers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with type 2 diabetes mellitus presents to a primary care clinic for a routine chronic disease management visit. The patient reports intermittent polyuria and recent weight gain; previous glycemic control has been suboptimal. The clinician orders an HbA1c (A1C) laboratory test during the visit to assess long-term glycemic control. The blood draw is performed in the outpatient clinic laboratory or at the point-of-care device in the clinic. The result returns with an HbA1c value greater than 9.0 percent, indicating poor control. The clinician documents the most recent A1C > 9% in the chart, considers medication adjustments, reinforcing lifestyle counseling, and schedules closer follow-up. Typical workflow: patient check-in → vitals and brief history → specimen collection (venipuncture or point-of-care capillary) → lab processing → result documented in electronic medical record and addressed during the visit.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no special circumstance modifier applies to the service |
PN | Private insurance payer-specific modifier (example use varies by payer) |